Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Antiseizure Medications on Complete Blood Count Parameters Among Egyptian Children With Epilepsy

NCT07883980 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07883980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Antiseizure Medications on Complete Blood Count Parameters Among Egyptian Children With Epilepsy
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
March 1, 2028
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 1 arm.

  • Children with Epilepsy on Antiseizure Medications

    Newly diagnosed children with epilepsy who will receive antiseizure medications and undergo serial complete blood count assessments.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in platelet count At 3 months

    Mean change in platelet count from baseline after initiation of antiseizure medication.

Lead sponsor's other trials

Assiut University, most recent start first.

Similar trials

Same condition (Epilepsy) and phase, most recent start first.